4476 - 4500 of 5898 Results
Title
Year
- Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress2017OPENTitle: Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0862-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0862-1Citation Count: 30
- Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression2017OPENTitle: Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal DepressionJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 980End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.011Best OA location URL: http://manuscript.elsevier.com/S1064748117303032/pdf/S1064748117303032.pdfCitation Count: 28
- Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies2017OPENTitle: Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 11Start Page: 1237End Page: 1250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.03.001Best OA location URL: https://europepmc.org/articles/pmc5647200?pdf=renderCitation Count: 27
-
OPENTitle: Association between autonomic dysfunction and fatigue in Parkinson diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 377Issue #:Start Page: 190End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2017.04.023Best OA location URL: https://europepmc.org/articles/pmc5536106?pdf=renderCitation Count: 22
-
OPENTitle: Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's DiseaseJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 37Issue #: 18Start Page: 4830End Page: 4840Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.2208-16.2017Best OA location URL: https://www.jneurosci.org/content/jneuro/37/18/4830.full.pdfCitation Count: 211
- Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease2017OPENTitle: Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 128Issue #: 2Start Page: 605End Page: 616Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2016.11.jns161162Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/128/2/article-p605.pdfCitation Count: 120
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017OPENTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 31
- Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts2017OPENTitle: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational effortsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 6Start Page: 1544End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx107Best OA location URL: https://academic.oup.com/brain/article-pdf/140/6/1544/18186427/awx107.pdfCitation Count: 18
- Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases2017OPENTitle: Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset casesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.04.006Best OA location URL: http://www.prd-journal.com/article/S1353802017301360/pdfCitation Count: 18
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://europepmc.org/articles/pmc5870749?pdf=renderCitation Count: 1
- Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.32017OPENTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 65
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5704913?pdf=renderCitation Count: 13
- Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease2017OPENTitle: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 43Issue #: 7Start Page: 604End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12402Best OA location URL: https://europepmc.org/articles/pmc5632188?pdf=renderCitation Count: 54
- Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway2017OPENTitle: Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathwayJournal Name: HippocampusPublisher: WileyVol: 27Issue #: 7Start Page: 784End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22731Best OA location URL: https://europepmc.org/articles/pmc5501956?pdf=renderCitation Count: 21
-
OPENTitle: A sensitive assay reveals structural requirements for α-synuclein fibril growthJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 22Start Page: 9034End Page: 9050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.767053Best OA location URL: http://www.jbc.org/article/S0021925820427061/pdfCitation Count: 22
-
OPENTitle: Integrated molecular landscape of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0015-3Best OA location URL: https://www.nature.com/articles/s41531-017-0015-3.pdfCitation Count: 109
- Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine2017OPENTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3Citation Count: 3
- Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss2017OPENTitle: Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron lossJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 60Issue #:Start Page: 99End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.03.008Best OA location URL: https://europepmc.org/articles/pmc5499677?pdf=renderCitation Count: 43
-
OPENTitle: Parkinson disease in Gaucher diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0054-2Best OA location URL: https://doi.org/10.1186/s40734-017-0054-2Citation Count: 13
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 50
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 67
- Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization2017OPENTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 83
- Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses2017OPENTitle: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0012-6Best OA location URL: https://www.nature.com/articles/s41531-017-0012-6.pdfCitation Count: 34
-
OPENTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://doi.org/10.1038/s41531-017-0010-8Citation Count: 229
- The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK22017OPENTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://europepmc.org/articles/pmc6178381?pdf=renderCitation Count: 33